NeuroSense Therapeutics Ltd.
PrimeC
ALS
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for PrimeC in ALS are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“following positive Phase 2b PARADIGM results”